Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 8-K | 10-K | 8-K | 10-K | S-1/A | S-1/A |
| Revenues: |
| Dry Eye | | | | | | 1.0 | |
| Surgical Glaucoma | | | | | | 22.3 | 7.5 |
| Total revenues | 71.3 | 71.3 | 49.0 | 49.0 | 27.6 | 23.3 | 7.5 |
| Revenue growth [+] | 45.7% | 45.7% | 77.1% | | 18.4% | 210.1% | |
| Surgical Glaucoma | | | | | | 196.2% | |
| Cost of goods sold | 12.4 | 12.4 | 8.6 | 8.6 | 9.2 | 6.5 | 2.3 |
| Gross profit | 59.0 | 59.0 | 40.3 | 40.3 | 18.4 | 16.8 | 5.2 |
| Gross margin | 82.7% | 82.7% | 82.4% | 82.4% | 66.7% | 72.0% | 69.0% |
| Selling, general and administrative | 120.1 | 120.1 | 76.2 | 76.2 | 41.7 | 32.7 | 14.1 |
| Research and development | 22.9 | 22.9 | 15.6 | 15.6 | 8.9 | 8.1 | 5.4 |
| EBITDA [+] | | | | | | -23.7 | -14.2 |
| EBITDA growth | 63.1% | 63.1% | 59.9% | | 35.6% | 66.8% | |
| EBITDA margin | -117.7% | -117.7% | -105.2% | -105.2% | -116.5% | -101.7% | -189.0% |
| Depreciation and amortization | | | | | | 0.3 | 0.1 |
| EBIT [+] | -84.0 | -84.0 | -51.5 | -51.5 | -32.2 | -24.0 | -14.3 |
| EBIT growth | 63.1% | 63.1% | 59.9% | | 33.9% | 68.1% | |
| EBIT margin | -117.7% | -117.7% | -105.2% | -105.2% | -116.5% | -103.0% | -189.9% |
| Interest expense, net [+] | 4.5 | 4.5 | 4.4 | 4.4 | 2.4 | | |
| Interest expense | 4.5 | 4.5 | 4.4 | 4.4 | 2.4 | | |
| Interest income | | | | | 0.0 | | |
| Other income (expense), net | 2.2 | 2.2 | -6.9 | -6.9 | -0.1 | -1.8 | 0.0 |
| Pre-tax income | -86.2 | -86.2 | -62.8 | -62.8 | -34.6 | -25.9 | -14.3 |
| Income taxes | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Tax rate | | | | | | | 0.0% |
| Net income | -86.2 | 0.0 | -63.0 | 0.0 | -34.7 | 0.0 | 0.0 |
| Net margin | -120.9% | 0.0% | -128.6% | 0.0% | -125.5% | 0.0% | 0.0% |
| |
| Basic EPS [+] | ($1.80) | $0.00 | ($2.36) | $0.00 | ($3.71) | $0.00 | $0.00 |
| Growth | -23.5% | | -36.5% | | | | |
| Diluted EPS [+] | ($1.80) | $0.00 | ($2.36) | $0.00 | ($3.71) | $0.00 | $0.00 |
| Growth | -23.5% | | -36.5% | | | | |
| |
| Shares outstanding (basic) [+] | 47.8 | 47,849.1 | 26.7 | 26,734.1 | 9.4 | 9,387.1 | 9,222.7 |
| Growth | 79.0% | 79.0% | 185.7% | | -99.9% | 1.8% | |
| Shares outstanding (diluted) [+] | 47.8 | 47,849.1 | 26.7 | 26,734.1 | 9.4 | 9,387.1 | 9,222.7 |
| Growth | 79.0% | 79.0% | 185.7% | | -99.9% | 1.8% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|